Development of a new method for detection of platelet factor 3 like activity.
We asked the question, "Can thalassemic erythrocytes play some role in alteration of the hemostatic system?", because clinical examination of thalassemic patients shows symptoms and signs related to alterations in hemostatic and circulatory systems, and thalassemic erythrocytes are different from normal erythrocytes. We obtained one of the answers to the question: The erythrocytes of postsplenectomized patients of beta-thalassemia/HbE disease could stimulate their own platelets to aggregate spontaneously. To know the role of erythrocytes in platelet aggregation, we wanted to examine the effect of thalassemic erythrocytes on the coagulation system by focusing of PF3-like activity of erythrocytes, because PF3-like activity of the ghosts of erythrocytes had been reported. For the study, we tried to develop a technique that was accurate and sensitive enough to detect PF3-like activity of blood. The system we developed was the following: 1) We activated the intrinsic coagulation pathway of commercial standard plasma by ellagic acid. 2) CaCl2, a fixed amount of PF 3 and synthetic thrombin inhibitor MD 805 were added to the reaction mixture. 3) At a fixed time, thrombin activity in the mixture was measured by using S-2238 as a substrate. At full activation of the contact system by ellagic acid, the amount of thrombin formed in a certain time depended on the amount of PF3-like substances such as cephalin, freeze-thawed platelets or ghosts of erythrocytes added to the test system, indicating that PF3-like activity of those substances can be measured by the activity of thrombin generated in a fixed time.(ABSTRACT TRUNCATED AT 250 WORDS)
Opartkiattikul
N
N
Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Funahara
Y
Y
Hijikata-Okunomiya
A
A
Yamaguchi
N
N
Talalak
P
P
D001780:Blood Coagulation Tests / Q000379:methods / Q000592:standards*; D004492:Edetic Acid; D004910:Erythrocyte Membrane / Q000737:chemistry / Q000502:physiology; D004913:Erythrocytes, Abnormal / Q000737:chemistry* / Q000502:physiology; D005069:Evaluation Studies as Topic; D006446:Hemoglobin E; D006453:Hemoglobinopathies / Q000097:blood* / Q000453:epidemiology / Q000601:surgery; D006801:Humans; D010714:Phosphatidylethanolamines; D010974:Platelet Aggregation; D010977:Platelet Factor 3 / Q000737:chemistry* / Q000502:physiology; D012680:Sensitivity and Specificity; D013156:Splenectomy; D013917:Thrombin / Q000096:biosynthesis; D017086:beta-Thalassemia / Q000097:blood* / Q000453:epidemiology / Q000601:surgery
D010714:Phosphatidylethanolamines; D010977:Platelet Factor 3; D006446:Hemoglobin E; D004492:Edetic Acid; D013917:Thrombin